Fact checked by Nick Blackmer Some long COVID patients who took an extended course of Paxlovid saw temporary or lasting ...

Influenza viruses have not evolved resistance to suraxavir marboxil, which relieves cough, fever and other symptoms.

Extended-course nirmatrelvir/ritonavir yields a meaningful reduction in symptoms for some patients with long COVID, but not all benefits persist.